HU-308 (specifically binds to Cannabinoid receptor 2) attenuates lung fibrosis by inhibiting BLM-induced polarization of mouse Th2 cells through the specific activation of Cannabinoid Receptor 2 (CB2) on CD4+T cells (118). The gene discussed is CD4; the disease is pulmonary fibrosis.